Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis.

Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis.

BACKGROUND AND AIMS:Expression of carbonic anhydrase IX (CA9), an enzyme expressed in response to hypoxia, acidosis and oncogenic alterations, is reported to be a prognostic factor in HCC patients. Here we evaluated serum CA9 levels in HCC and cirrhosis patients. METHODS:HCC and cirrhosis patients w...

Full description

Bibliographic Details
Main Authors: Fabian Finkelmeier, Özge Canli, Kai-Henrik Peiffer, Dirk Walter, Andrea Tal, Christine Koch, Ursula Pession, Johannes Vermehren, Jörg Trojan, Stefan Zeuzem, Albrecht Piiper, Florian R Greten, Georgios Grammatikos, Oliver Waidmann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6047828?pdf=render

Internet

http://europepmc.org/articles/PMC6047828?pdf=render

Similar Items